Related Experiment Video
Updated: Aug 16, 2025

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
Published on: May 15, 2019
MAD2B Blunts Chronic Unpredictable Stress and Corticosterone Stimulation-Induced Depression-Like Behaviors in Mice
Xiao-Lan Wang1,2, Cheng Miao2, Yanfang Su2
1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Background:
Depression is a prevalent and recurrent psychiatric disorder. Aberrant neural structure and activity play fundamental roles in the occurrence of depression. Mitotic arrest deficient protein (MAD2B) is highly expressed in neurons and may be implicated in synaptic plasticity in the central nervous system. However, the effect of MAD2B in depression, as well as the related molecular mechanism, is uncertain.
Methods:
Here, we employed mouse models of depression induced by chronic unpredictable stress exposure or corticosterone (CORT) stimulation. Depression-like behaviors in mice were evaluated by sucrose preference, forced swimming, and tail suspension tests. Hippocampal MAD2B overexpression was mediated by adeno-associated virus 8 containing enhanced green fluorescent protein. In vitro primary neuronal cells were obtained from the hippocampus of rat embryos and were treated with CORT, and MAD2B overexpression was performed using lentivirus. MAD2B and glutamate metabotropic receptor 4 (GRM4) levels were evaluated by western blots and quantitative PCR. Primary neuronal miR-29b-3p expression was detected by quantitative PCR.
Results:
MAD2B expression was reduced in the hippocampus in mice exhibiting depressive-like behaviors. However, hippocampal MAD2B overexpression protected mice from developing either chronic unpredictable stress- or CORT-induced depression-like behaviors, an effect associated with reduced expression of GRM4, a presynaptic receptor involved in depression. Moreover, MAD2B overexpression in primary neuronal cells also decreased GRM4 expression while enhancing the level of miR-29b-3p; this phenomenon was also observed under CORT stimulation.
Conclusions:
Our results suggest an important role of neuronal MAD2B in the pathogenesis of depression via the miR-29b-3p/GRM4 signaling pathway. MAD2B could be a potential therapeutic target for depressive disorders.
Insights
Mitotic arrest deficient protein (MAD2B) plays a key role in depression. Increasing MAD2B in the brain protected against depression-like behaviors by regulating the miR-29b-3p/GRM4 pathway, suggesting MAD2B as a therapeutic target.
Area of Science:
- Neuroscience
- Molecular Biology
- Psychiatry
Background:
- Depression is a common and recurring psychiatric disorder linked to abnormal neural structure and activity.
- Mitotic arrest deficient protein (MAD2B), highly expressed in neurons, may influence central nervous system synaptic plasticity.
- The specific role of MAD2B in depression and its underlying molecular mechanisms remain unclear.
Purpose of the Study:
- To investigate the role of MAD2B in depression.
- To elucidate the molecular mechanisms by which MAD2B affects depression.
- To explore MAD2B as a potential therapeutic target for depressive disorders.
Main Methods:
- Mouse models of depression were established using chronic unpredictable stress and corticosterone (CORT) stimulation.
- Depression-like behaviors were assessed using sucrose preference, forced swimming, and tail suspension tests.
- MAD2B and glutamate metabotropic receptor 4 (GRM4) levels were analyzed, alongside miR-29b-3p expression, in hippocampal tissues and primary neuronal cells.
Main Results:
- MAD2B expression was decreased in the hippocampus of mice exhibiting depression-like behaviors.
- Overexpression of MAD2B in the hippocampus protected mice against depression-like behaviors induced by stress or CORT.
- MAD2B overexpression reduced GRM4 expression and increased miR-29b-3p levels in neuronal cells, an effect also observed under CORT stimulation.
Conclusions:
- Neuronal MAD2B is crucial in depression pathogenesis through the miR-29b-3p/GRM4 signaling pathway.
- MAD2B demonstrates potential as a therapeutic target for depressive disorders.
- Further research into the MAD2B pathway could yield novel depression treatments.
More Related Videos
06:55An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
06:15A Multiple Integrated Social Stress Model for Psychiatric Disorders in Female C57BL/6J Mice
Published on: July 15, 2025